8Bonnick S, Saag KG, Kiel DP, et al. Comparison of postmenopausal osteoporosis with alendronate versus risedronate over two years [ J ]. J Clin Endocrinol Melab ,2006,91 (7) :2631 - 2637. 被引量:1
9Keams E. Receptor activator of nuclear factor kappaB lig - and and osteoprotegerin regulation of bone remodeling in health and disease [J]. EndocrRev,2008,29(4):155-192. 被引量:1
10Seeman E, De Veruejoul MC,Adami S. Strontiumranelate reduces the risk of no nvertebral fractures in postmen opausa women with os-teoporosis[ J]. J Clin Endocrinol Metab,2005,90(5) :2816 -2822. 被引量:1